The trademark application CMM was filed by Indigo Diabetes N.V., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 26, 2021, and it was registered by office on August 4, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1621149 at the World Intellectual Property Organization (WIPO).
The application was filed in Dutch (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on May 10, 2023. Appointment and Replacement of representative of the trademark registration was recorded on July 11, 2023.